WO2022065970A3 - Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection - Google Patents

Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection Download PDF

Info

Publication number
WO2022065970A3
WO2022065970A3 PCT/KR2021/013194 KR2021013194W WO2022065970A3 WO 2022065970 A3 WO2022065970 A3 WO 2022065970A3 KR 2021013194 W KR2021013194 W KR 2021013194W WO 2022065970 A3 WO2022065970 A3 WO 2022065970A3
Authority
WO
WIPO (PCT)
Prior art keywords
natural product
prevention
mixed extract
product mixed
treatment
Prior art date
Application number
PCT/KR2021/013194
Other languages
French (fr)
Korean (ko)
Other versions
WO2022065970A2 (en
Inventor
마진열
조원경
Original Assignee
한국한의학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020210067200A external-priority patent/KR102640794B1/en
Application filed by 한국한의학연구원 filed Critical 한국한의학연구원
Publication of WO2022065970A2 publication Critical patent/WO2022065970A2/en
Publication of WO2022065970A3 publication Critical patent/WO2022065970A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to an antiviral use of a natural product mixed extract or a fraction thereof against coronaviruses and, more specifically, to an antiviral pharmaceutical composition against coronaviruses, a pharmaceutical composition for prevention or treatment of coronavirus infection diseases, each pharmaceutical composition comprising a natural product mixed extract or a fraction thereof, a method for prevention or treatment of coronavirus infection diseases by using the pharmaceutical composition, a health functional food composition comprising a natural product mixed extract or a fraction thereof for prevention or alleviation of coronavirus infection diseases, and a feed composition comprising a natural product mixed extract or a fraction thereof for prevention or alleviation of coronavirus infection diseases. The natural product mixed extract of the present invention exhibits the effect of inhibiting the infection of coronaviruses such as MERS coronavirus, SARS coronavirus, and SARS coronavirus 2 and as such, can be used for developing an antiviral agent for preventing or treatment of the viral diseases.
PCT/KR2021/013194 2020-09-28 2021-09-28 Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection WO2022065970A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20200126186 2020-09-28
KR10-2020-0126186 2020-09-28
KR10-2021-0067200 2021-05-25
KR1020210067200A KR102640794B1 (en) 2020-09-28 2021-05-25 Composition for preventing or treating corona virus comprising herbal mixing extracts

Publications (2)

Publication Number Publication Date
WO2022065970A2 WO2022065970A2 (en) 2022-03-31
WO2022065970A3 true WO2022065970A3 (en) 2022-05-19

Family

ID=80846754

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/013194 WO2022065970A2 (en) 2020-09-28 2021-09-28 Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection

Country Status (1)

Country Link
WO (1) WO2022065970A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101513247B1 (en) * 2013-06-17 2015-04-20 구미경 A composition comprising extracts of herbal mixture for treating or preventing respiratory disease
KR20160019834A (en) * 2014-08-12 2016-02-22 한국 한의학 연구원 Composition for the prevention and treatment of antiviral comprising extracts of Epimedium koreanum
KR101951203B1 (en) * 2015-09-24 2019-02-25 주식회사 씨엔에이치코퍼레이션 A composition for preventing or treating respiratory cancers comprising herbal ingredients
KR20190083769A (en) * 2018-01-05 2019-07-15 알리코제약(주) Compositions for preventing or treating respiratory diseases containing Lionicerae Flower extract

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101513247B1 (en) * 2013-06-17 2015-04-20 구미경 A composition comprising extracts of herbal mixture for treating or preventing respiratory disease
KR20160019834A (en) * 2014-08-12 2016-02-22 한국 한의학 연구원 Composition for the prevention and treatment of antiviral comprising extracts of Epimedium koreanum
KR101951203B1 (en) * 2015-09-24 2019-02-25 주식회사 씨엔에이치코퍼레이션 A composition for preventing or treating respiratory cancers comprising herbal ingredients
KR20190083769A (en) * 2018-01-05 2019-07-15 알리코제약(주) Compositions for preventing or treating respiratory diseases containing Lionicerae Flower extract

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BHUIYAN FARHANA RUMZUM, HOWLADER SABBIR, RAIHAN TOPU, HASAN MAHMUDUL: "Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic", FRONTIERS IN MEDICINE, vol. 7, XP055929542, DOI: 10.3389/fmed.2020.00444 *
CHO WON-KYUNG, KIM HYUNIL, CHOI YU JEONG, YIM NAM-HUI, YANG HYE JIN, MA JIN YEUL: "Epimedium koreanum Nakai Water Extract Exhibits Antiviral Activity against Porcine Epidermic Diarrhea Virus In Vitro and In Vivo", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, OXFORD UNIVERSITY PRESS, US, vol. 2012, 1 January 2012 (2012-01-01), US , pages 1 - 10, XP055929543, ISSN: 1741-427X, DOI: 10.1155/2012/985151 *
SHIN, HYUN-SOO: "Coronavirus Replication Inhibition by Herbal Extracts", MASTER THESIS, 1 February 2007 (2007-02-01), Korea, pages 1 - 31, XP009536717 *

Also Published As

Publication number Publication date
WO2022065970A2 (en) 2022-03-31

Similar Documents

Publication Publication Date Title
WO2021207409A3 (en) Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
AU2021260618A8 (en) Antiviral application of nucleoside analog or combination formulation containing nucleoside analog
JOP20220179A1 (en) N4-hydroxycytidine and derivatives and anti-viral uses related thereto
MXPA05008368A (en) Hiv inhibiting 1,2,4-triazines.
AP2088A (en) Phenethanolamine derivatives for treatment of respiratory diseases
MXPA04002405A (en) Phenethanolamine derivatives for treatment of respiratory diseases.
UA100005C2 (en) Inhibitors of human immunodeficiency virus replication
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MX2010002410A (en) Oral compositions, products, and methods of use.
MX2021010213A (en) Coronavirus therapeutic agent comprising elaeocarpus sylvestris extract as active ingredient.
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
WO2005076761A3 (en) Composition for preenting a cold
MX2022005985A (en) Pyrazolo-heteroaryl derivative, preparation method therefor, and medical use thereof.
MX2022015601A (en) Compound for the treatment of coronaviral infections.
HUP0300732A2 (en) Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
ZA202211004B (en) 3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
WO2022192594A3 (en) Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2022065970A3 (en) Composition comprising natural product mixed extract for prevention or treatment of coronavirus infection
AU2010323104A8 (en) Sialochimeric compounds
PT1796702E (en) Use of lavender oil for the prophylaxis and treatment of somatization disorders and posttraumatic stress disorder
BRPI0413714A (en) milk fractions and milk preparations for the treatment and / or prevention of cox-2 mediated diseases
WO2019022478A3 (en) Composition containing gryllus bimaculatus extract as active ingredient for improving skin wrinkles or moisturizing skin
MX2022005909A (en) Composition for prevention, alleviation, or treatment of respiratory disease.
MX2022012321A (en) Virucidal compositions and use thereof.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21872998

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21872998

Country of ref document: EP

Kind code of ref document: A2